Immunoprecipitation on magnetic beads and liquid chromatography-tandem mass spectrometry for carbonic anhydrase II quantification in human serum

Analytical Biochemistry

Volumn 400, Issue 2, 2010, Pages 195-202

  Callipo, Luciano ^a   Caruso, Giuseppe ^a   Foglia, Patrizia ^a   Gubbiotti, Riccardo ^a   Samperi, Roberto ^a   Laganà, Aldo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Biomarkers; Carbonic anhydrase; Immunobeads; Serum proteins; Tandem mass spectrometry

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BIOMARKERS; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDES;

IMMUNOBEADS; LABELED INTERNAL STANDARDS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MULTIPLE REACTION MONITORING; RELATIVE STANDARD DEVIATIONS; SERUM PROTEINS; TANDEM MASS SPECTROMETRY;

CARBONIC ANHYDRASE;

CARBONATE DEHYDRATASE II; SYNTHETIC PEPTIDE; TRYPSIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN DEGRADATION; PROTEIN PURIFICATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STOICHIOMETRY; TANDEM MASS SPECTROMETRY; VOLUNTEER;

EID: 77950689437     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.01.039     Document Type: Article

References (35)

1. Schiess R., Wollscheid B., Aabersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol. Oncol. 2009, 3:33-44.
2. Grossklaus D.J., Smith J.A., Shappell S.B., Coffey C.S., Chang S.S., Cookson M.S. The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. Urol. Oncol. 2002, 7:195-198.
3. Whitehouse C., Solomon E. Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening. Gynecol. Oncol. 2003, 88:S152-S157.
4. Jaffe A.S. Cardiovascular biomarkers: the state of the art in 2006. Clin. Chim. Acta 2007, 381:9-13.
5. Pernemalm M., Lewensohn R., Lehtiö J. Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion. Proteomics 2009, 9:3414-3424.
6. Addona T.A., Abbatiello S.E., Schilling B., Skates S.J., Mani D.R., Bunk D.M., Spiegelman C.H., Zimmerman L.J., Ham A.-J.L., Keshishian H., et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27:633-641.
7. Tanaka Y., Akiyama H., Kuroda T., Jung G., Tanahashi K., Sugaya H., Utsumi J., Kawasaki H., Hirano H. A novel approach and protocol for discovering extremely low-abundance proteins in serum. Proteomics 2006, 6:4845-4855.
8. Urbas L., Brne P., Gabor B., Barut M., Strliè M., Èerk Petriè T., Štrancar A. Depletion of high-abundance proteins from human plasma using a combination of an affinity and pseudo-affinity column. J. Chromatogr. A 2009, 1216:2689-2694.
9. Jmeian Y., El Rassi Z. Liquid-phase-based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids for in-depth proteomics analysis. Electrophoresis 2009, 30:249-261.
10. Melm C., Schuchard M., Chen D.E., Duewel H. Examination of non-specifically bound proteins and peptides following depletion of twenty high abundance proteins from human plasma. Life Sci. Innov. 2008, 24:17-20. (Sigma-Aldrich).
11. Zhou M., Lucas D.A., Chan K.C., Issaq H.J., PetricoinIII E.F., Liotta L.A., Veenstra T.D., Conrads T.P. An investigation into the human serum " interactome" Electrophoresis 2004, 25:1289-1298.
12. Gong Y., Li X., Yang B., Ying W., Li D., Zhang Y., Dai S., Cai Y., Wang J., He F., Qian X.J. Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J. Proteome Res. 2006, 5:1379-1387.
13. Zolotarjova N., Martosella J., Nicol G., Bailey J., Boyes B.E., Barrett W.C. Differences among techniques for high-abundant protein depletion. Proteomics 2005, 5:3304-3313.
14. Hannan N.J., Stoikos C.J., Stephens A.N., Salamonsen L.A. Depletion of high-abundance serum proteins from human uterine lavages enhances detection of lower-abundance proteins. J. Proteome Res. 2009, 8:1099-1103.
15. Stempfer R., Kubicek M., Lang I.M., Christa N., Gerner C. Quantitative assessment of human serum high-abundance protein depletion. Electrophoresis 2008, 29:4316-4323.
16. Freije J.R., Bischoff R. The use of affinity sorbents in targeted proteomics. Drug Discov. Today 2006, 3:5-11.
17. Safarik I., Safarikova M. Magnetic techniques for the isolation and purification of proteins and peptides. Biomagn. Res. Technol. 2004, 2:7-24.
18. Kitteringham N.R., Jenkins R.E., Lane C.S., Elliott V.L., Park B.K. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. B 2009, 877:1229-1239.
19. Domon B., Aebersold R. Mass spectrometry and protein analysis. Science 2006, 312:212-217.
20. Monaci L., Visconti A. Mass spectrometry-based proteomics methods for analysis of food allergens. Trends Anal. Chem. 2009, 28:581-591.
21. Sechi S. Quantitative Proteomics by Mass Spectrometry (Methods in Molecular Biology) 2007, Humana Press, Totowa, NJ, p. 359.
22. Bantscheff M., Schirle M., Sweetman G., Rick J., Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem. 2007, 389:1017-1031.
23. Sly W.S., Hu P.Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 1995, 64:375-401.
24. Tashian R.E., Hewett-Emmett D., Dodgson S.J., Forster R.E., Sly W.S. The value of inherited deficiencies of human carbonic anhydrase isozymes to our understanding of their cellular roles. Ann. NY Acad. Sci. 1984, 429:284-286.
25. Palminiello S., Kida E., Kaur K., Walus M., Wisniewski K.E., Wierzba-Bobrowicz T., Rabe A., Albertini G., Golabek A.A. Increased levels of carbonic anhydrase II in the developing Down syndrome brain. Brain Res. 2008, 1190:193-205.
26. Vlkolinský R., Cairns N., Fountoulakis M., Lubec G. Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol. Aging 2001, 22:547-553.
27. Callipo L., Foglia P., Gubbiotti R., Samperi R., Laganà A. HPLC-CHIP coupled to a triple quadrupole mass spectrometer for carbonic anhydrase II quantification in human serum. Anal. Bioanal. Chem. 2009, 394:811-820.
28. Yocum A.K., Yu K., Oe T., Blair I.A. Effect of immunoaffinity depletion of human serum during proteomic investigations. J. Proteome Res. 2005, 4:1722-1731.
29. Berna M.J., Zhen Y., Watson D.E., Hale J.E., Bradley L.A. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal. Chem. 2007, 79:4199-4205.
30. Kamiie J., Ohtsuki S., Iwase R., Ohmine K., Katsukura Y., Yanai K., Sekine Y., Uchida Y., Ito S., Terasaki T. Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm. Res. 2008, 25:1469-1483.
31. Mallick P., Schirle M., Chen S.S., Flory M.R., Lee H., Martin D., Ranish J., Raught B., Schmitt R., Werner T., Kuster B., Aebersold R. Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 2007, 25:125-131.
32. Barnidge D.R., Dratz E.A., Martin T., Bonilla L.E., Moran L.B., Lindall A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem. 2003, 75:445-451.
33. Careri M., Elviri L., Lagos J.B., Mangia A., Speroni F., Terenghi M. Selective and rapid immunomagnetic bead-based sample treatment for the liquid chromatography-electrospray ion-trap mass spectrometry detection of Ara h3/4 peanut protein in foods. J. Chromatogr. A 2008, 1206:89-94.
34. Whiteaker J.R., Zhao L., Zhang H.Y., Feng L.C., DPiening B., Anderson L., Paulovich A.G. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal. Biochem. 2007, 362:44-54.
35. McIntosh M., Fitzgibbon M. Biomarker validation by targeted mass spectrometry. Nat. Biotechnol. 2009, 27:622-623.